Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity of YF-VAX in Adults with Prior Vaccination
NCT05859490Phase 2Recruiting
- Sponsor
- Oregon Health & Science University
- Start
- Aug 2023
- Primary completion
- Nov 2025
- Modality
- Live Attenuated Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of 17D yellow fever vaccine in yellow fever, sponsored by Oregon Health & Science University. Started Aug 2023; status: recruiting.
02
Drugs
17D yellow fever vaccine
03
Conditions
yellow fever
Beyond the preview
Go deeper on NCT05859490.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05859490.